Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $44.67.
A number of research firms have recently commented on TRUP. Piper Sandler lifted their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Northland Securities boosted their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Bank of America raised their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Finally, Stifel Nicolaus upped their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd.
Check Out Our Latest Analysis on TRUP
Trupanion Trading Down 1.3 %
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The company had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. Trupanion’s revenue was up 14.6% on a year-over-year basis. During the same period last year, the business posted ($0.10) earnings per share. Research analysts anticipate that Trupanion will post -0.23 EPS for the current fiscal year.
Insider Activity
In other Trupanion news, SVP Emily Dreyer sold 3,100 shares of the firm’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $54.85, for a total value of $170,035.00. Following the completion of the transaction, the senior vice president now owns 24,708 shares in the company, valued at $1,355,233.80. This trade represents a 11.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Steve Weinrauch sold 11,916 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $53.00, for a total value of $631,548.00. Following the sale, the executive vice president now owns 48,978 shares in the company, valued at approximately $2,595,834. This represents a 19.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 28,405 shares of company stock valued at $1,512,482 over the last quarter. Company insiders own 5.50% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Hedge funds have recently bought and sold shares of the company. Quest Partners LLC bought a new stake in shares of Trupanion during the 3rd quarter valued at about $37,000. Wilmington Savings Fund Society FSB purchased a new position in Trupanion in the third quarter worth $54,000. GAMMA Investing LLC increased its stake in Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 596 shares during the last quarter. Entropy Technologies LP bought a new stake in Trupanion during the third quarter worth about $202,000. Finally, Mutual of America Capital Management LLC purchased a new position in shares of Trupanion in the 3rd quarter worth about $210,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Election Stocks: How Elections Affect the Stock Market
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.